Benzinga | Sep 13, 2021 04:08PM EDT

Rani Therapeutics Hldgs Q2 EPS $(0.12) Down From $(0.06) YoY, Sales $1.96M Up From $60.00K YoY

Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.12) per share. This is a 100 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $1.96 million in sales this quarter. This is a 3.17K percent increase over sales of $60.00 thousand the same period last year.